Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries

被引:15
|
作者
Giannopoulos, Stefanos [1 ]
Strobel, Aaron [1 ]
Rudofker, Eric [1 ]
Kovach, Christopher [1 ]
Schneider, Peter A. [2 ]
Armstrong, Ehrin J. [1 ]
机构
[1] Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, Denver, CO 80202 USA
[2] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA
关键词
dissection; endovascular therapy; drug-coated balloon; paclitaxel coated balloon; peripheral artery disease; LOWER-EXTREMITY; ENDOVASCULAR INTERVENTIONS; TASK-FORCE; DISEASE; MANAGEMENT; CALCIFICATION; CONSENSUS; PATTERNS; SURGERY; IMPACT;
D O I
10.1177/15266028211016441
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Balloon angioplasty for the treatment of femoropopliteal lesions is often complicated by postangioplasty dissections. While dissections are known to affect patency and reintervention after balloon angioplasty, the association between dissections and major adverse limb event (MALE) after drug-coated balloon (DCB) angioplasty remains uncertain. Thus, the postangioplasty dissection and bailout stenting patterns were investigated. Materials and Methods: This was a single-center retrospective study enrolling patients with de novo femoropopliteal lesions treated with DCB with/without stenting. Postangioplasty target vessel dissection was graded based to the coronary artery classification grades A-F, with grade C-F considered "severe." Cox regression analysis was performed to examine the association of dissection severity with outcomes during 2-year follow up, among nonstented cases. Results: In 85.3% of the cases (N=203/238) a postangioplasty dissection was observed. The average dissection length was 55.57 mm (SD 36.71 mm), with 1 dissection present in 91.8% (N=180/196) and 2 or more dissections present in 8.2% (N=16/196). Dissection severity was grade A (19.8%), B (20.6%), C (23.1%), D (10.9%), E (10.1%), and F (0.8%). Bailout stenting was required in 40.4% of the patients, being more prevalent among grade C and grade E cases. Among 142 nonstented cases, dissections were present in 85.2%. A total of 75 (52.8%) of these dissections were grade A and B, while 46 (32.4%) were grade C to F. Among nonstented cases, grade C (hazard ratio [HR] 5.83; 95% CI 1.25 to 27.31; p=0.025) and grade D (HR 6.32; 95% CI 1.39 to 28.86; p=0.017) vs grade A dissections were associated with a higher risk for 2-year MALE. Multivariate analysis adjusting for several lesion characteristics demonstrated a statistically significant higher risk for 2-year MALE among the severe dissection group (HR 2.94; 95% CI 1.27 to 6.79; p = 0.012). Interestingly, the risks of limb loss (HR 1.30; 95% CI 0.22 to 7.79; p=0.774) and repeat revascularization (HR 0.95; 95% CI 0.40 to 2.26; p=0.905) during follow-up were similar between the 2 groups. Conclusion: This study indicated that nonstented moderate and severe postangioplasty dissections after DCB angioplasty were associated with higher risk for MALE. Future studies are needed to validate our results and determine other dissection characteristics (eg, total dissection length, lumen area, total number of dissections) that may affect the efficacy of DCB.
引用
收藏
页码:593 / 603
页数:11
相关论文
共 50 条
  • [21] Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries
    Mohapatra, Abhisekh
    Saadeddin, Zein
    Bertges, Daniel J.
    Madigan, Michael C.
    Al-Khoury, Georges E.
    Makaroun, Michel S.
    Eslami, Mohammad H.
    JOURNAL OF VASCULAR SURGERY, 2020, 71 (02) : 560 - 566
  • [22] Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries
    Mohapatra, Abhisekh
    Bertges, Daniel J.
    Madigan, Michael C.
    Al-Khoury, Georges E.
    Makaroun, Michel S.
    Eslami, Mohammad H.
    JOURNAL OF VASCULAR SURGERY, 2018, 68 (02) : E15 - E16
  • [23] Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions
    Haraguchi, Takuya
    Kuramitsu, Shoichi
    Tsujimoto, Masanaga
    Kashima, Yoshifumi
    Sato, Katsuhiko
    Fujita, Tsutomu
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 103 (01) : 97 - 105
  • [24] Clinical Outcomes of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon Alone in the Treatment of Femoropopliteal Artery Disease
    Cha, Jung-Joon
    Lee, Jae-Hwan
    Ko, Young-Guk
    Roh, Jae-Hyung
    Yoon, Yong-Hoon
    Lee, Yong-Joon
    Lee, Seung-Jun
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    KOREAN CIRCULATION JOURNAL, 2022, 52 (02) : 123 - 133
  • [25] Mid-Term Outcomes of Orbital Atherectomy Combined with Drug-Coated Balloon Angioplasty for Treatment of Femoropopliteal Disease
    Foley, T. Raymond
    Cotter, Ryan P.
    Kokkinidis, Damianos G.
    Nguyen, Daniel D.
    Waldo, Stephen W.
    Armstrong, Ehrin J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 89 (06) : 1078 - 1085
  • [26] Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions
    Yigit, Gorkem
    VASCULAR, 2022, 30 (04) : 739 - 748
  • [27] Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions
    Shirai, Shigemitsu
    Hirano, Keisuke
    Mori, Shinsuke
    Makino, Kenji
    Honda, Yosuke
    Tsutsumi, Masakazu
    Sakamoto, Yasunari
    Kobayashi, Norihiro
    Araki, Motoharu
    Yamawaki, Masahiro
    Ito, Yoshiaki
    HEART AND VESSELS, 2021, 36 (12) : 1818 - 1824
  • [28] Frequency, predictors, and effect of the slow-flow phenomenon after drug-coated balloon angioplasty for femoropopliteal lesions
    Shigemitsu Shirai
    Keisuke Hirano
    Shinsuke Mori
    Kenji Makino
    Yosuke Honda
    Masakazu Tsutsumi
    Yasunari Sakamoto
    Norihiro Kobayashi
    Motoharu Araki
    Masahiro Yamawaki
    Yoshiaki Ito
    Heart and Vessels, 2021, 36 : 1818 - 1824
  • [29] Femoropopliteal Drug-coated Balloon Angioplasty: Long-term Results of the Randomized EffPac Trial
    Teichgraeber, Ulf
    Lehmann, Thomas
    Aschenbach, Rene
    Thieme, Markus
    Zeller, Thomas
    Beschorner, Ulrich
    Scheinert, Dierk
    RADIOLOGY, 2022, 304 (01) : 225 - 227
  • [30] Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans
    Su, Z.
    Li, Y.
    Yang, S.
    Guo, J.
    Guo, L.
    Gu, Y.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2022, 104 (09) : 667 - 672